Integra Lifesciences Holdings Cash Flow Statement (2009-2026) | IART

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
35.07M43.23M45.38M32.90M44.79M49.91M52.95M24.23M4.18M19.50M19.83M-3.28M-12.40M-10.70M19.43M-25.29M-484.07M-5.40M-1.70M-4.62M
Share-based Compensation (Quarter)
15.70M7.75M6.43M6.29M6.74M8.97M5.73M3.62M5.27M5.46M5.79M5.60M7.24M4.38M7.15M1.87M5.29M5.58M5.84M5.17M
Deferred Taxes (Quarter)
-3.67M-8.59M10.74M3.54M4.00M-6.10M-6.02M1.95M-0.23M1.24M-14.85M-2.86M-1.84M-9.04M-6.99M-1.83M-44.83M-8.65M-10.95M1.33M
Cash from Discontinued Operations (Quarter)
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)
-4.02M-0.16M5.34M9.20M-15.00M-13.68M44.10M4.70M0.64M0.21M0.31M3.12M0.08M0.17M0.14M-0.49M0.29M2.76M0.14M1.38M
Asset Writedowns and Impairment (Quarter)
7.10M5.04M7.10M0.04M511.37M
Non-cash Items (Quarter)
Cash from Operations (Quarter)
91.29M82.78M69.28M44.34M66.48M68.31M85.33M26.16M28.28M26.77M58.75M15.76M40.40M22.48M50.74M-11.26M8.92M40.91M11.82M9.80M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortizatization of Intangibles (Quarter)
0.81M2.78M1.72M1.72M1.67M1.75M1.70M1.89M1.42M1.42M1.43M1.40M1.46M1.33M1.40M1.39M1.89M1.31M1.01M0.99M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
29.75M30.12M30.75M29.72M29.61M29.47M29.50M31.14M30.83M30.56M30.98M30.57M36.78M35.96M37.59M37.19M37.69M38.52M38.43M38.43M
Change in Working Capital
Change in Receivables (Quarter)
5.95M-6.63M10.17M3.12M6.52M14.24M10.04M-10.04M5.21M-0.22M0.46M-16.83M6.72M-28.75M31.46M-21.45M27.99M-22.51M16.45M-13.64M
Change in Inventory (Quarter)
-5.22M6.49M-8.97M11.56M6.01M6.87M4.68M25.42M2.13M15.79M16.42M19.02M-1.74M10.30M0.57M13.70M6.38M23.34M3.34M4.33M
Change in Accured Expenses (Quarter)
12.83M6.58M-0.98M-9.75M-4.80M13.75M18.15M-4.98M-10.91M-6.24M1.91M-19.21M15.07M6.83M-5.36M-18.00M15.92M5.78M23.02M-19.19M
Other Working Capital Changes (Quarter)
10.14M-0.48M0.03M-2.28M3.06M-2.40M3.81M0.43M-1.43M0.11M9.43M-0.34M2.51M-0.35M1.72M1.39M0.96M2.65M-1.59M21.88M
Investing Activities
Capital Expenditures (Quarter)
6.63M7.29M27.43M9.32M9.41M9.15M14.46M13.70M15.55M13.08M24.54M15.46M29.71M29.65M29.60M28.92M20.15M15.16M17.21M14.85M
Sales of Property, Plant and Equipment (Quarter)
0.00M11.14M
Acquisitions (Quarter)
Divestments (Quarter)
-1.27M23.96M
Change in Acquisitions & Divestments (Quarter)
0.08M-0.08M-4.91M35.25M7.00M
Cash from Investing Activities (Quarter)
-7.92M-8.47M-27.48M-14.07M-4.50M14.80M-54.82M-13.70M-15.55M-7.70M-57.23M-53.97M-322.20M-10.40M-4.25M-35.92M-21.65M-15.59M-34.91M-14.85M
Financing Activities
Other financing activities (Quarter)
0.25M7.58M0.30M0.07M0.13M
Cash from Financing Activities (Quarter)
-97.47M1.74M0.52M-133.47M-13.15M-7.64M-97.70M-162.68M-10.69M-49.66M-6.89M358.68M-93.75M-19.91M-7.15M35.38M-21.14M-10.24M24.34M8.30M
Additional items
Exchange Rate Effect (Quarter)
2.54M-3.23M0.90M-3.17M-8.77M-10.69M11.91M0.94M-0.21M-4.87M8.04M-4.96M-1.12M7.75M-8.12M4.53M12.68M-0.80M1.61M-1.49M
Change in Cash (Quarter)
-11.56M72.82M43.22M-106.36M40.06M64.78M-55.28M-149.29M1.82M-35.46M2.67M315.50M-376.67M-0.08M31.22M-7.27M-21.19M14.27M2.86M1.76M
Free Cash Flow (Quarter)
84.66M75.49M41.85M35.02M57.07M59.16M70.88M12.45M12.73M13.69M34.22M0.29M10.69M-7.16M21.14M-40.18M-11.23M25.75M-5.40M-5.04M
Net Cash Flow (Quarter)
-14.10M76.05M42.31M-103.19M48.83M75.48M-67.19M-150.23M2.04M-30.59M-5.37M320.47M-375.55M-7.83M39.34M-11.80M-33.87M15.07M1.25M3.25M